Hexo NYSE: HEXO
Hexo Corp, formerly Hydropothecary Corp, is a Canada-based company that creates and distributes products to serve the Canadian cannabis market.
Name | Hexo |
Ticker | HEXO |
Exchange | NYSE |
Sector | Health Care |
Industry | Cannabis Finance |
Price | 6.69 |
52W Low/High | 1.45 / 7.21 |
Market cap | 430 M |
1Y Total Return |
18.62%
Above Average |
1Y Volatility |
144.51%
High Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Hexo Corp, formerly Hydropothecary Corp, is a Canada-based company that creates and distributes products to serve the Canadian cannabis market.
Details
Ticker | HEXO |
Name | Hexo |
ISIN | |
CUSIP | |
Exchange | NYSE |
Sector | Health Care |
Industry | Cannabis Finance |
Country | Canada |
Currency | U.S. Dollar |
Share as of 1/22/21
Close Price | 6.69 |
52W Low/High | 1.45 / 7.21 |
Market cap | 430 M |
1Y Total Return |
18.62%
Above Average |
1Y Volatility |
144.51%
High Risk |
Beta | 0.01 |
PE (trailing) | - |
12M Dividends | - |
Last Dividend Date | - |
Dividend Yield | - |
Fin. Strength
Net Profit Margin | -676.5% |
Cash from Op. / Cur. Liabilities | -1.15 |
Diluted Earnings / Share | -5.28 |
ROE | - |
ROIC | -90.1% |
Price / Revenue | 8.6 |
Price / Book | 1.3 |
Price / CF | -7.3 |
Current Ratio | 3.7 |
Cur.Liabilities / Tot.Liabilities | 0.6 |
Financial Leverage | 0.21 |
in Mils USD |
rolling-year up to June
|
|||
---|---|---|---|---|
Income Statement | 2020 | 2019 | 2018 | |
Revenue |
60
|
36
|
4
|
|
Gross Profit |
-
|
19
|
5
|
|
R&D |
3
|
2
|
0
|
|
EBITDA |
-405
|
-67
|
-15
|
|
Operating Income |
-356
|
-66
|
-14
|
|
Net Income exc. Extra |
-
|
-
|
-
|
|
per Share | ||||
Diluted avg Shares |
77
|
53
|
34
|
|
EPS exc. Extra |
-5.28
|
-1.01
|
-0.52
|
|
Dividend |
-
|
-
|
-
|
|
Div. Yield (an.) |
-
|
-
|
-
|
|
Balance Sheet | 2020 | 2019 | 2018 | |
Total Assets |
517
|
671
|
254
|
|
Cash, Eq & Invt ShortTerm |
137
|
117
|
193
|
|
Total Current Assets |
228
|
238
|
210
|
|
Total Non-Current Assets |
289
|
432
|
44
|
|
Intangibles |
12
|
183
|
3
|
|
Total Liabilities |
102
|
69
|
9
|
|
Total Current Liabilities |
62
|
63
|
9
|
|
Long Term Debt |
40
|
5
|
0
|
|
Shareholder equity |
413
|
601
|
245
|
|
Cash Flow | 2020 | 2019 | 2018 | |
Cash from Operations |
-71
|
-95
|
-17
|
|
Depreciation |
0
|
0
|
1
|
|
Cash from Investing |
-62
|
-6
|
-152
|
|
Capex |
73
|
105
|
35
|
|
Cash from Financing |
185
|
112
|
215
|
|
Stock Issued |
150
|
90
|
114
|
|
Debt (LT) Issued |
43
|
25
|
52
|
|
Free Cash Flow |
-411
|
-55
|
-
|
|
Ratios | 2020 | 2019 | 2018 | |
Net Profit Margin |
-
|
-
|
-
|
|
NCFO / Op.Income |
-
|
-
|
-
|
|
Current Ratio |
3.7
|
3.8
|
22.8
|
|
Financial Leverage D/E |
0.21
|
0.08
|
0.00
|
|
Return on Capital Avg |
-90.1%
|
-4.1%
|
-19.5%
|
|
Return on Shareholder Equity |
-
|
-
|
-
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available